glycomics-glycobiology-market

Glycomics/ Glycobiology Market By Product Type (Enzymes, Instruments, Kits, Reagents), By Application (Diagnostics, Drug Discovery & Development, Oncology, Immunology) - Growth, Future Prospects, And Competitive Analysis, 2024 -2032

03 Sep 2017 Format PDF icon PPT icon XLS icon Request Sample

Glycomics or glycobiology is the study of the structure, function, biosynthesis, and biology of carbohydrates, often called glycans that are widely distributed in nature. Increasing applicability of glycobiology in biotechnology and pharmaceutical industries, growing number of biopharmaceutical industries and rising research institutes are major factors that assist the growth of glycobiology market globally.  

The report titled “Glycomics/ Glycobiology Market - Growth, Future Prospects and Competitive Analysis, 2023–2030” offers strategic insights into the overall glycobiology market along with the market size and estimates for the duration 2020 to 2030. The research study covers in-depth analysis of market segments based on product type (enzymes, instruments and kits), application (diagnostics, drug discovery & development, oncology, immunology, other applications) and different geographical regions.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global glycomics/ glycobiology market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global glycomics/ glycobiology market. This report concludes with company profiles section that highlights major information about the key players engaged in global glycomics/ glycobiology market. In-depth competitive environment analysis and historical years (2020) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global glycobiology market, offering market size and estimates for the period from 2020 to 2030, keeping in mind the above-mentioned factors. 

Glycomics or glycobiology is the study of the structure, function, biosynthesis, and biology of carbohydrates, often called glycans which are widely distributed in nature. Glycomics/ glycobiology is a rapidly growing field in biology, with relevance to biomedicine, biotechnology, biofuels and basic research. Growing interest in biomolecular and biomedical research for glycobiology is prime factor that driving market growth around the globe. For the purpose of this study, glycomics/ glycobiology market is segmented on the basis of product type, among the considered market segment enzymes will show highest growth during forecast period due to its consumable nature and increasing use in variety of R&D and drug discovery procedures. Enzymes utilized as useful tool to understand carbohydrate structure and function.

Currently, instruments held the largest market share due to the higher costs and their primary role in structure and function detection. It is observed that among the instruments segment, mass spectrometers is major revenue contributing segment because higher sensitivity, accuracy, specificity are fueling market growth. Furthermore, these accurate machines are coupled with advanced data analysis and fingerprinting programs that can accurately determine the structure of complex glycan molecules.

Glycomics or glycobiology is the study of the structure, function and biology of saccharides, it is a fast emerging field of interest for biomolecular and biomedical research around the globe. Glycobiology market is growing rapidly worldwide because saccharides play primary role in almost every aspect of the cellular processes ranging from cell-cell interactions, energy intermediates, adhesion mechanisms, growth factor signaling, blood clotting, receptor binding, regulating the activity of hormones in the blood, directing embryonic development. It is observed that, in the base year 2021, drug discovery & development held the largest market share due to increase in R&D activities for the development of novel therapies and large number of unmet needs for treatment of chronic diseases.

It is observed that in the base year 2021, North America was largest revenue contributor in global glycomics/ glycobiology market; the market growth is mainly driven by the progress of United States. Technological advancement, higher investment in research and development activities, presence of large number of biotechnology, biopharmaceutical and pharmaceutical industries, presence of large number of research institutes and growing life science industries are major factors that driving the glycomics/ glycobiology market in North America. However, Asia Pacific will show highest growth during forecast period due to increasing investments in the life sciences sector and rapidly expanding biopharmaceutical industries in the region. Emerging Asian countries such as China and India expected to drive market growth due increasing R&D activities and growing partnership of key players with local manufacturers.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Glycomics/ Glycobiology market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Glycomics/ Glycobiology market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Product
  • Enzymes
    •     Glycosidases
    •     Glycosyltransferases
    •     Neuraminidases
    •     Sialyltransferases
    •     SulfatasesCarbohydrate Kinases
    •     Carbohydrate Kinases
    •     Other Enzymes
  • Instruments
    •     Antibody Arrays
    •     HPLC
    •     Lectin Arrays
    •     MALDI-TOF
    •     Mass Spectrometers
    •     Other Instruments
  • Kits
    •     Glycan Labeling Kits
    •     Glycan Purification Kits
    •     Glycan Release Kits
    •     Other Kits
  • Reagents
    •     Glycoproteins
    •     Monosaccharides
    •     Oligosaccharides
    •     Other Reagents

Application
  • Diagnostics
  • Drug Discovery & Development
  • Oncology
  • Immunology
  • Other Applications

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Glycomics/ Glycobiology market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Glycomics/ Glycobiology market?
  • Which is the largest regional market for Glycomics/ Glycobiology market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Glycomics/ Glycobiology market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Glycomics/ Glycobiology market worldwide?
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports